Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · IEX Real-Time Price · USD
0.383
+0.015 (4.19%)
At close: May 17, 2024, 4:00 PM
0.388
+0.005 (1.20%)
After-hours: May 17, 2024, 7:58 PM EDT
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $23.46 million as of May 17, 2024. Its market cap has decreased by -73.67% in one year.
Market Cap
23.46M
Enterprise Value
-27.79M
1-Year Change
-73.67%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $229.70M to $23.46M, a decrease of -89.79%. That is a compound annual growth rate of -43.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 23.30M | 4.02% |
| May 16, 2024 | 22.40M | 3.23% |
| May 15, 2024 | 21.70M | -4.41% |
| May 14, 2024 | 22.70M | 2.71% |
| May 13, 2024 | 22.10M | -2.64% |
| May 10, 2024 | 22.70M | -3.81% |
| May 9, 2024 | 23.60M | -0.84% |
| May 8, 2024 | 23.80M | -7.03% |
| May 7, 2024 | 25.60M | -19.50% |
| May 6, 2024 | 31.80M | -87.06% |
| May 3, 2024 | 245.70M | -12.96% |
| May 2, 2024 | 282.30M | -11.81% |
| May 1, 2024 | 320.10M | 1.75% |
| Apr 30, 2024 | 314.60M | 11.32% |
| Apr 29, 2024 | 282.60M | 0.21% |
| Apr 26, 2024 | 282.00M | -8.71% |
| Apr 25, 2024 | 308.90M | -1.15% |
| Apr 24, 2024 | 312.50M | 0.39% |
| Apr 23, 2024 | 311.30M | - |
| Apr 22, 2024 | 311.30M | 0.39% |
| Apr 19, 2024 | 310.10M | -3.70% |
| Apr 18, 2024 | 322.00M | -0.28% |
| Apr 17, 2024 | 322.90M | 0.09% |
| Apr 16, 2024 | 322.60M | 2.48% |
| Apr 15, 2024 | 314.80M | -0.19% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 25.04M |
| Unity Biotechnology | 24.87M |
| CytoMed Therapeutics | 24.58M |
| NanoViricides | 24.40M |
| Aesthetic Medical International Holdings Group | 23.85M |
| Iterum Therapeutics | 23.18M |
| NeuroBo Pharmaceuticals | 23.06M |
| Lisata Therapeutics | 22.93M |